You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
上海萊士(002252.SZ):目前血液製品特別是人血白蛋白、靜注人免疫球蛋白兩類產品處於供需緊平衡狀態
格隆匯 06-07 18:01

格隆匯6月7日丨上海萊士(002252.SZ)於2023年6月6日下午13:00-14:00召開網絡會議,交流互動環節中,就“請介紹下公司未來的收入、利潤增長方向?”,公司回覆稱,目前,血液製品特別是人血白蛋白、靜注人免疫球蛋白兩類產品處於供需緊平衡狀態。公司擁有四個生產主體,除自產血液製品外,公司還代理進口人血白蛋白產品,產品種類齊全,可以對應不同的市場需求,有利於公司在市場端的議價能力,體現協同效應。同時,公司將進一步提升原料血漿在凝血因子類產品的綜合利用率,未來將逐步擴大凝血因子類產品市場份額,提升公司利潤。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account